Central African Republic vs Lebanon: Average cost of multi drug-resistant tuberculosis treatment
Central African Republic
1,043 constant 2022 US$
in 2024
Lebanon
1,020 constant 2022 US$
in 2024
Central African Republic rank
46th
Lebanon rank
47th
Average cost of multi drug-resistant tuberculosis treatment over time
- Central African Republic
- Lebanon
How they compare
Central African Republic currently reports 1,043 constant 2022 US$ against 1,020 constant 2022 US$ in Lebanon, a difference of 23 constant 2022 US$.
The two have swapped places 2 times across 7 shared years of data; in 2017 it was Central African Republic ahead.
Central African Republic ranks 46th and Lebanon ranks 47th of 92 countries.
Across the 2 decades both report, Central African Republic averaged higher in 1 and Lebanon in 1.
Head to head by decade
| Decade | Central African Republic | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,461 constant 2022 US$ | 1,443 constant 2022 US$ | 18.33 constant 2022 US$ | Central African Republic |
| 2020s | 1,080 constant 2022 US$ | 1,208 constant 2022 US$ | 128.25 constant 2022 US$ | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Central African Republic or Lebanon?
- Central African Republic, at 1,043 constant 2022 US$ against 1,020 constant 2022 US$ in Lebanon as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Central African Republic and Lebanon?
- 23 constant 2022 US$, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Lebanon?
- 7 years are reported by both, from 2017 to 2024.
- How do Central African Republic and Lebanon rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Central African Republic ranks 46th and Lebanon ranks 47th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.